logo
Base Child Care Crunch Could Be Solved by Partnerships, Home-Run Day Cares, Pentagon Says

Base Child Care Crunch Could Be Solved by Partnerships, Home-Run Day Cares, Pentagon Says

Yahoo2 days ago

As the Pentagon continues to struggle with long wait times and limited availability at its child care facilities, officials say that they are exploring off-base partnerships and growing programs that enable spouses to set up child care centers in their homes.
"The department is pursuing a number of child care solutions to meet service members and their families where they are," Tim Dill, a top official in the Pentagon's personnel and readiness office, told Military.com in an exclusive statement Tuesday.
"In some cases, that is in DoD child development centers, but in others, it may be by helping to cover the cost of in-home child care providers," Dill added.
Read Next: Trump Pardons Former Army Officer Convicted of Disobeying COVID-19 Safety Rules
Earlier this month, dozens of families at Holloman Air Force Base in New Mexico were told their children would be disenrolled from the base day care. Similar cases have cropped up at other Army, Air Force and Space Force bases, with the Navy also acknowledging staffing challenges at its child development centers.
The reduced capacity at base day cares has been partly driven by the Trump administration's push to cut civilian federal employees at the Defense Department as well as other federal agencies.
In an exclusive interview with Military.com last week, a defense official at the personnel and readiness office said the Pentagon is now looking to create new positions at military child development centers -- a lead educator position in each classroom and then a special needs inclusion coordinator for each center -- to offer upward mobility for employees and "push toward the retention effort."
However, the effort overall seems to be shifting from staffing or building new centers on base to programs that aim to have others shoulder some of the burden as well. One potential solution under consideration is to partner with outside groups like the Armed Forces YMCA to operate child care centers off base.
The official, who spoke to Military.com on the condition their name not be used, said that earlier in May the Pentagon opened one such center in Norfolk, Virginia, which has a large Navy population.
"It's a 200-child-space center that is exclusively for DoD families, and we anticipate opening another one this December here in the National Capital Region -- in the Arlington area -- and then another one down in Virginia Beach next spring," the official said.
The three centers would provide roughly 600 spaces for children in areas that have some of the longest wait times for military families, the official explained.
The official also said that they are pushing forward with a program that buys out space in existing civilian child care centers to boost capacity for military families, with the goal to lease locations in San Diego as well as in the Newport News-Hampton, Virginia, area.
"We'll be looking in the next month or so to expand that also to the National Capital Region," the official added.
The struggle to build and staff child care centers was already a problem before President Donald Trump's effort to downsize the government. It's an issue that the military has struggled with for years -- and one that has also become a nationwide problem, exacerbated by the COVID-19 pandemic.
Officials within the services have noted that the effort of staffing a child care center is not only challenging, but the pay is not enough.
Last fall, a pair of senators even pushed Defense Secretary Pete Hegseth's predecessor, Lloyd Austin, to increase military child care workers' pay as quickly as possible.
"Congress and military families are counting on DoD to update its compensation model for direct care staff expeditiously so DoD can hire and retain more caregivers, and more military families can find the care they need," the senators wrote in a letter to Austin.
In March, Military.com reported that, because enough day care employees either voluntarily took a deferred resignation offer from the administration or fell within a probationary employment period targeted for firings by the White House's Office of Personnel Management, Hill Air Force Base in Utah was getting ready to scale back its child care center, potentially leaving Gold Star spouses and other defense employees in the lurch.
Several weeks later, the base closed one of its two child care centers.
Navy officials also told Military.com that "administrative delays" had temporarily halted their ability to extend job offers and bring on new child care staffers.
"While the Navy is in the process of filling vacant positions due to turnover or need for seasonal staff, military families may experience child care disruptions such as reduced capacity for summer camps, reduced operating hours for certain programs, canceled activities, disenrollment of lower prioritized families, suspension of before-school care, or a pause on new enrollments," the service warned in early May.
The Pentagon's considered fixes so far are focused on major metropolitan areas, but service members in more remote areas have said such efforts may offer little help to them due to limited surrounding communities for the military to tap into.
When asked about those concerns, the official said the Pentagon hopes to also grow a program that enables spouses to set up small child care centers in their own homes.
However, that program is also not without issues.
One spouse at Holloman Air Force Base, located in a rural area of New Mexico, told Military.com earlier this month that those programs take months to get going because of the vetting and certification processes. Given that families typically live in one place for only a few years, those delays mean that any one house would act as a child care center for only a year or two, assuming an application was filed immediately upon arrival.
The official noted that the department has also been working with some states "for the last couple of years to recognize the DoD certification in place of requiring a state license or issuing a state license on the basis that they are a DoD-certified home" in order to enable the program to run more smoothly.
Ultimately, the official said that, while the Pentagon is "all-in, committed to quality life for our families ... there's just different nuances in every service on how they execute hiring." As a result, the official said, any issues with breaks in service rest with each individual branch and not the personnel and readiness office.
Related: Parents Still Struggle to Get Details on Abuse at Military Day Care Centers Despite Watchdog Probe

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

‘60 Minutes' has history of cozy interviews and self-promotion
‘60 Minutes' has history of cozy interviews and self-promotion

New York Post

time28 minutes ago

  • New York Post

‘60 Minutes' has history of cozy interviews and self-promotion

Beware of those who publicly declare that their stuff doesn't stink. Recently, CBS newsman and '60 Minutes' regular Scott Pelley made news and noise when he seized the close of the venerable program to deliver an appeal, threat or whatever, depending on how one heard it, to CBS News parent Paramount, as it was reportedly preparing to settle a lawsuit brought last year by President Trump over the show's very cozy interview with VP Kamala Harris during last year's presidential campaign. Pelley cited the week's resignation of '60 Minutes' executive producer, Bill Owens, adding, 'Paramount began to supervise our content in new ways. None of our stories has been blocked, but Bill felt he lost the independence that honest journalism requires. … Bill made sure they were accurate and fair. Advertisement 'He was tough that way, but our parent company Paramount is trying to complete a merger. The Trump administration must approve it.'

FDA OKs new COVID-19 vaccine for 65 and older, others with conditions
FDA OKs new COVID-19 vaccine for 65 and older, others with conditions

UPI

time36 minutes ago

  • UPI

FDA OKs new COVID-19 vaccine for 65 and older, others with conditions

A vial of the Moderna COVID-19 vaccine in the Meuhedet Clinic in Jerusalem on January 3, 2022. The FDA approved a new version of the vaccine on Friday. File photo by Debbie Hill/UPI | License Photo May 31 (UPI) -- The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened vaccine standards for the virus. The FDA announced Friday that mNEXSPIKE can be given to adults 65 and older and those 12 to 64 with at least one underlying condition that could put them at risk of severe infection. Recipients also must have been previously vaccinated for COVID-19. The company, headquartered in Cambridge, Mass., said Saturday it expects to have the vaccine available for the 2025-2026 respiratory virus season. Moderna also produces Spikevax for COVID-19, and mRESVIA for the respiratory syncytial virus, or RSV. "The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19," Stéphane Bancel, chief executive officer of Moderna, said. "COVID-19 remains a serious public health threat, with more than 47,000 Americans dying from the virus last year alone. We appreciate the FDA's timely review and thank the entire Moderna team for their hard work and continued commitment to public health." STAT reported the next-generation COVID-19 vaccine uses a refined target to generate antibodies against the SARS-CoV-2 virus. The dose is one-fifth the doage used in Spikevax, the current vaccine. Moderna conducted a randomized, observer-blind Phase 3 clinical trial of approximately 11,400 participants aged 12 years and older to test the mRNA-1283. The primary efficacy was to demonstrate the vaccine efficacy against COVID-19 starting 14 days after mNEXSPIKE compared with Spikevax, Moderna's updated COVID-19 vaccine approved on Sept. 6, 2024. The new vaccine showed a 9.3% higher relative vaccine efficacy than the mRNA-1273 in individuals aged 12 years and older. It was 13.5% better in adults aged 65 and older. In the Phase 3 trial, the most common side effects were injection site pain, fatigue, headache and myalgia. The company said there is a very small chance that mNEXSPIKE could cause a severe allergic reaction, usually within a few minutes to 1 hour after getting a dose of mNEXSPIKE. Myocarditis, which is inflammation of the heart muscle, and pericarditis, which is inflammation of the lining outside the heart, have occurred in some people who have received mRNA COVID-19 vaccines, Moderna said. Of those with problems, they are among males12 through 24. The FDA has asked Moderna to conduct post-marketing studies to continue to evaluate the safety and effectiveness of the product. This includes a study on the outcomes of pregnant people and their babies when the vaccine was administered during pregnancy. The study is to be submitted by the end of 2032. Pfizer was the first COVID-19 vaccine to receive emergency approval in December 2020 and Moderna was followed one week later. The first COVID-19 cases were reported in the United States in January 2020. The FDA first granted Pfizer-BioNTech full COVID-19 approval for those 12 and older in August 2021 and Moderna in January 2022. They remain available under emergency use authorization for children as young as 6 months. On Friday, the Centers for Disease Control and Prevention said children without underlying health conditions "may receive" a COVID-19 vaccine, contradicting a directive by Health and Human Services Secretary Robert F. Kennedy Jr. earlier in the week. The CDC updated the childhood immunization schedule published late Thursday. Kennedy, who said the agency would stop recommending the shots for healthy children, noted the guidelines would be changed. The new schedule also requires health insurance companies, Medicare and Medicaid plans to continue to cover the vaccines for children. COVID-19 shots during pregnancy are listed as "No Guidance/Not Applicable," where they were previously recommended for all pregnant adults. Earlier this month, the FDA approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay. The agency approved the vaccine only for people 65 and older and those 12 and older with at least one underlying condition at a higher risk of severe illness. This week, HHS notified Moderna that it was canceling contracts worth $766 million to develop, test and license vaccines for flu subtypes that could trigger future pandemics, including the dangerous H5N1 bird flu virus. The first COVID-19 case was reported in the United States on Jan. 20, 2020. About 23% of U.S. adults are estimated to be up to date with the vaccine, according to the CDC through April. For children 6 months and up to 18, it is an estimated 13.%, the CDC reported.

Puerto Rico is Trump's perfect partner in reshoring
Puerto Rico is Trump's perfect partner in reshoring

The Hill

time40 minutes ago

  • The Hill

Puerto Rico is Trump's perfect partner in reshoring

President Trump recently signed an executive order to bring pharmaceutical manufacturing back to the U.S. by streamlining the process for the Food and Drug Administration to approve pharmaceutical manufacturing plants. This is the latest in the Trump administration's agenda to protect national security and create American jobs by promoting the reshoring of critical supply chains that Americans rely on every day. These efforts are coupled with international tariffs to encourage domestic manufacturing. Reshoring pharmaceutical manufacturing is not only dire for American national security, but it could have resounding economic impacts across the country. One U.S. jurisdiction that is ready and in a perfect position to partner in this effort is Puerto Rico, where pharmaceutical manufacturing is already a more than $50 billion industry. With complementary efforts underway in Congress and on the island, the White House should look to Puerto Rico as America's pharmaceutical powerhouse while not trapping the island in its current territory status by hindering a future transition to statehood that would further boost the island's manufacturing ability. As a territory, the island is part of the U.S. customs zone and is not subject to U.S. tariffs, and everything that is made in Puerto Rico is 'Made in the USA.' Yet, that same territory status has limited Puerto Rico's economic development by creating persistent uncertainty, underinvestment and an unequal playing field for economic competition. The territory status is unpopular on the island, and Puerto Rican voters have voted in favor of statehood four consecutive times, most recently last November. Trump and Congress have the opportunity of a generation to leverage the pharmaceutical infrastructure and workforce in Puerto Rico to achieve their agenda while also turbocharging the economy on the island, and they have the perfect ally in Puerto Rico to do it with — the island's Republican Gov. Jenniffer González-Colón. González-Colón is leading an ambitious agenda to reshape the national narrative about the island and its people — and ultimately achieve statehood for Puerto Rico. Aligning with the Trump administration's vision to reshore advanced manufacturing of critical products, she issued an executive order in late March and reached out to top White House officials to offer Puerto Rico's well-established, yet currently underutilized, manufacturing capacity as an economic engine to help grow American prosperity. González-Colón's executive order promotes the relocation of overseas manufacturing of pharmaceuticals and other products to Puerto Rico. Much like Trump's executive order, it eliminates barriers and streamlines the process for businesses to move to the island. This action is complementary to the Medical Manufacturing, Economic Development and Sustainability Act, which was recently reintroduced and incentivizes pharmaceutical manufacturing on the island and throughout economically distressed zones across the United States. The bill is designed to attract business to the island in a way that invests in the people of Puerto Rico. It does this by providing an incentive for medical manufacturing facilities to relocate to economically distressed zones, with an incentive dependent on the number of jobs created to ensure money is flowing back into communities. The incentive itself is based on economic factors and applies to communities throughout the United States — an appropriately wide scope that comports with Trump's strong desire to reshore large amounts of production in a short time frame. By tethering the tax credits to what manufacturers invest directly into wages, salaries and real middle-class benefits, the proposal creates good-paying, quality American jobs. Reshoring to Puerto Rico would mean that critical pharmaceuticals and medical devices, as well as other products that are currently manufactured overseas in China and other nations, would now be produced in America. This would create thousands of well-paying manufacturing jobs that Puerto Rico needs to turbocharge the modest economic progress it's made in recent years. The increased consumer demand on the island would help boost the approximately $70 billion in annual interstate commerce, resulting in more jobs and profits stateside. Puerto Rico is a natural partner in reshoring the medical and pharmaceutical manufacturing industry within U.S. borders. The island's leaders share in the White House's vision of a more prosperous pharmaceutical manufacturing industry and are working to ensure reshoring efforts do not trap Puerto Rico in its current territory status but instead enable it to reach its full potential as an engine of economic growth and prosperity as a future state of our Union. Manufacturing makes America stronger, especially when it lifts up communities and the hard-working American citizens that make 'Made in the USA' a possibility, including those in Puerto Rico.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store